Description: H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts, components, and medical consumables for medical technology, automotive, and other traditional industries. It provides emulsifiers and bases, waxes and emulsions, petroleum jellies, water-based waxes and oil-emulsions, motor and process oils, cable filling compounds. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany
Home Page: www.hur.com
Neuenkirchener Strasse 8
Salzbergen,
48499
Germany
Phone:
49 59 76 9 45 0
Officers
| Name | Title |
|---|---|
| Mr. Niels H. Hansen | Member of Executive Board & Sole MD |
| Prof. Wolfgang Hartwig Ph.D. | Chief Financial Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Chemicals |
| GIC Sub-Industry: | Commodity Chemicals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 22.4 |
| Price-to-Book MRQ: | 0.2971 |
| Price-to-Sales TTM: | 0.0947 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1658 |